EVP R&D, Chief Medical Officer
Wed, Apr 1, 2026
Apr 1
5,000 shares @ $19.34
Increased holdings by +5.60%
58th largest trade (out of 152)
Trade made by an officer
10b5-1 scheduled trade
39% win rate · -4.2% median edge vs SPY (23 trades, 90-day)
Insider trade was 45% below market price
Price 18% above 200-day moving average